Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$5.29B
+21.8% from 2023
Prescriptions
5.6M
$938.93 per claim
Patients
1.3M
266,350 prescribers
Total spending, 2024
$5.29B
$4,168.36 per patient
Medicare prescription drug plans paid $5.29B for Farxiga in 2024, for 5,632,811 prescriptions and refills to 1,268,791 patients (up 21.8% from 2023). The average cost per claim was $938.93.
Texas had the highest Medicare cost for Farxiga in 2024: $470.4M for 474,557 claims, followed by California ($450.5M).
Wei Y Sun, nephrology in New York, NY, had the highest Medicare cost for Farxiga in 2024: 3,361 claims costing $2.2M.
Farxiga is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Wei Y Sun New York, NY | Nephrology | 3,361 | 561 | $2.2M |
| Mohammad A Chaudhry Union City, NJ | Internal Medicine | 1,822 | 436 | $1.9M |
| Carlos R Figueroa Nunez |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 178,604 | 2,664,228 | 638,606 | $2.58B |
| 2023 | 230,477 | 4,296,969 | 993,405 | $4.34B |
| 2024 | 266,350 | 5,632,811 | 1,268,791 | $5.29B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 2,106 |
| 401 |
| $1.4M |
| Francisco Pons Miami, FL | Internal Medicine | 1,968 | 457 | $1.3M |
| Ankush Gulati Lehigh Acres, FL | Nephrology | 1,028 | 321 | $1.3M |
| Minesh Rajpal Peoria, AZ | Nephrology | 1,068 | 270 | $1.2M |
| Manavendra Bakhshi Philadelphia, PA | Cardiology | 1,629 | 309 | $1.2M |
| Luis R Garcia-Mayol Coral Gables, FL | Nephrology | 1,429 | 303 | $1.2M |
| Paul-Moreau Bossous Mission, TX | Nephrology | 1,139 | 374 | $1.2M |
| Nhan T Luu Galion, OH | Nephrology | 1,006 | 285 | $1.2M |
| 1710074026 | Internal Medicine | 1,184 | 235 | $1.2M |
| Najmuddin K Karimjee Houston, TX | Internal Medicine | 1,073 | 358 | $1.1M |
| Carlos M Martinez Rivera Mayaguez, PR | Endocrinology | 1,548 | 310 | $1.1M |
| Eddie M Rodriguez-Castro Bayamon, PR | Nephrology | 903 | 293 | $1.1M |
| Ahed Mansoura Rome, GA | Endocrinology | 873 | 225 | $1.1M |
| Michael M Dao Garden Grove, CA | Internal Medicine | 1,002 | 257 | $1.0M |
| Eliscer Guzman New York, NY | Internal Medicine | 1,056 | 297 | $1.0M |
| Henry C Yee Alhambra, CA | Cardiology | 1,243 | 292 | $1.0M |
| Elizabeth Liang Flushing, NY | Nephrology | 1,509 | 263 | $996K |
| Glenn H Herrington Wilmington, NC | Pharmacist | 645 | 216 | $985K |
| Jose R Baez Lawrence, MA | Internal Medicine | 1,472 | 248 | $948K |
| Denise Caro Mayaguez, PR | Endocrinology | 1,302 | 234 | $941K |
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 1,165 | 234 | $910K |
| Maritza Melendez Nieves Fajardo, PR | Internal Medicine | 617 | 185 | $900K |
| Lisa O Cabrera San Antonio, TX | Nephrology | 1,153 | 271 | $896K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 5,634,650 | $5.29B |